The Impact of COVID-19 on Hypertension and Hypertension Medication Adherence Among Underrepresented Racial and Ethnic Groups: A Scoping Review.
Autor: | Foster M; Center for Healthcare Organization and Implementation Research (CHOIR), Boston, MA, USA. Marva.Foster@va.gov.; Boston University Chobanian & Avedisian School of Medicine, Department of General Internal Medicine, Boston, MA, USA. Marva.Foster@va.gov.; VA Boston Healthcare System, Department of Quality Management, 150 S. Huntington Ave., 02130, Boston, MA, USA. Marva.Foster@va.gov., Etchin A; VA Boston Healthcare System, Department of Quality Management, 150 S. Huntington Ave., 02130, Boston, MA, USA.; Boston University Chobanian & Avedisian School of Medicine, Department of Psychiatry, Boston, MA, USA., Pope C; Health Equity & Rural Outreach Innovation Center (HEROIC)/COIN, Ralph H. Johnson VA Health Care System, Charleston, SC, USA.; Department of Pediatrics, College of Medicine, Medical University of South Carolina, Charleston, SC, USA., Hartmann CW; VA Center for Healthcare Organization and Implementation Research (CHOIR), Bedford, MA, USA.; Department of Public Health, Zuckerberg College of Health Sciences, University of Massachusetts Lowell, Lowell, MA, USA., Emidio O; Center for Healthcare Organization and Implementation Research (CHOIR), Boston, MA, USA., Bosworth HB; Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham Veterans Affairs Medical Center, Durham, NC, USA.; Duke University School of Medicine, Department of Population Health Sciences, Durham, NC, USA.; Duke University School of Medicine, Department of Medicine, Division of General Internal Medicine, Durham, NC, USA.; Duke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, NC, USA.; Duke University Medical Center, School of Nursing, Durham, NC, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Current hypertension reports [Curr Hypertens Rep] 2023 Nov; Vol. 25 (11), pp. 385-394. Date of Electronic Publication: 2023 Aug 25. |
DOI: | 10.1007/s11906-023-01262-4 |
Abstrakt: | Purpose of Review: To conduct a scoping review of articles which examined the impact of COVID-19 on HTN and HTN medication adherence among underrepresented racial/ethnic minorities. Recent Findings: Seven studies were included in this review and impact of COVID-19 was examined at 4 levels: patient, provider, health system and society. The results indicated that patient level factors, such as high unemployment and inequitable access to telemedicine due to society factors- lack of access to high-speed Internet and variation in the offering of telehealth by health systems, were most impactful on adherence. Additionally, provider level clinical inertia may have further impacted adherence to HTN medication. Our review showed that the COVID-19 pandemic did not introduce new barriers but exacerbated preexisting barriers. Ongoing efforts are needed to change policies at the state and local levels to dismantle inequities in underrepresented communities to ensure access to health care with telemedicine to promote health equity. (© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.) |
Databáze: | MEDLINE |
Externí odkaz: |